Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. - Wikidata - awgldk - TriplyDB

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

http://www.wikidata.org/entity/Q33820188

about

Bone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMA Predictors of outcome in early-onset psychosis: a systematic review Early risk factors for adult bipolar disorder in adolescents with mood disorders: a 15-year follow-up of a community sample Generation of superoxide anion radicals and platelet glutathione peroxidase activity in patients with schizophrenia.Meta-analysis of oxidative stress in schizophrenia.Erythrocyte glutathione levels as long-term predictor of transition to psychosis Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.Accelerating neuronal aging in in vitro model brain disorders: a focus on reactive oxygen species Antioxidant defense system and family environment in adolescents with family history of psychosis.A Meta-Analysis of Oxidative Stress Markers in Depression.Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism The promise of biological markers for treatment response in first-episode psychosis: a systematic review.Multivariate genetic determinants of EEG oscillations in schizophrenia and psychotic bipolar disorder from the BSNIP study.Treatment of early onset schizophrenia: recent trends, challenges and future considerations.Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress.Antioxidants as potential therapeutics for neuropsychiatric disorders.Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders.Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk Potential synergistic action of 19 schizophrenia risk genes in the thalamus.Hormesis, cellular stress response and neuroinflammation in schizophrenia: Early onset versus late onset state.Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis.Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis Glutathione S-Transferase Deletion Polymorphisms in Early-Onset Psychotic and Bipolar Disorders: A Case-Control Study.First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model.Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.Peripheral levels of superoxide dismutase and glutathione peroxidase in youths in ultra-high risk for psychosis: a pilot study.Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.The complex association between the antioxidant defense system and clinical status in early psychosis.Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for Psychosis.

P2860

Q26775158-8383CBAB-BCFF-41F3-8840-A1E9B24AF9AB Q26859165-147414D4-82FD-4A4B-A889-16EB9D4BA86F Q30616696-366BB142-105F-4D90-AEAD-4DC4FB83594F Q33589462-3F6ED89E-134E-4D10-A703-8B3F75226393 Q33601360-84887562-6D27-43A0-A751-8F7D1C9FBABA Q33635566-BF440924-715F-4432-B44C-7D05478016BB Q33979025-B49E5B9E-5BB7-46CA-8D23-E09C5817B98D Q34406924-82E170ED-891C-4635-80A1-461BBD90DC26 Q34479923-24FF1103-322A-4D1B-9BBF-2EDD194DEEE5 Q34497237-74005D07-DBF2-4FDD-BD28-6AF38F6249CC Q34599738-2AE7DCEC-1E72-4467-9D85-68D0311F79F6 Q35369988-2D3DF0CC-442C-4B39-A3EA-B4DDF5740021 Q35813141-CCBCDF1A-9723-4317-A6EB-D5301E2732C3 Q35864793-38C01316-D968-4855-A76B-EDB8B63441B3 Q36702534-FF41F93C-0D51-470B-B7AA-96718AD37733 Q36736055-69157D30-BAEC-4208-826D-0A62E3DFE6FB Q37598239-93375624-8A5F-42AE-96B1-F6D80FE4BED8 Q37602622-EA643038-70AA-4FBB-855B-7D911B503B12 Q38901529-82378DEA-DDE9-4DD7-87DE-7EBF73E382FB Q38958804-1436E238-111E-41F6-9C3D-316FB95205D5 Q39023447-6C25BBE8-EA24-46A3-96CA-54719603EE4E Q39346412-9167A33E-2151-4DC1-B5B4-31B0EB42EA86 Q41611297-12557D20-C14F-49C5-86A0-026DB305EE4C Q41687474-53C3F82E-2250-4365-B9BE-75EB2E29751B Q41703320-F1D63D57-9AA8-426B-89D6-D999180EE118 Q41771204-D6B4ED2A-44D3-47BF-B74E-AA3BE29BBA11 Q42479721-B1C65FB5-CB85-49BC-9BDB-DB132A03993E Q43814726-6E4930ED-AD54-4ED5-9519-8781EEDBC488 Q46070080-FE7DCCF7-4C72-4ED3-9794-0EBC82F864D9 Q47297974-66D7312B-FC12-4F8E-B4D9-2A31FCF63071 Q50719449-88346E50-963A-48C5-86FB-48F0BDB1AD98 Q52308849-914F7F8A-EDC4-4C47-92F9-343A38213936 Q55262427-D5704FC0-CB3D-4CA8-BC8C-721E430D5204

P2860

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

http://www.wikidata.org/entity/Q33820188

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

@ast

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

@en

type

label

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

@ast

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

@en

prefLabel

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

@ast

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

@en

P1433

Q33820188-0394CF3E-76D8-42E5-B8F2-E6867015D66C

P1476

Q33820188-602ABD87-766E-434D-832A-F51ABE190927

P2093

Q33820188-10177E0E-A3CC-4A06-A39F-4C0225DFE5EA

Q33820188-3B521739-1444-48B5-8BBB-6F9D4D44F23D

Q33820188-3CBDD376-E5ED-4B61-8CCF-928074986BED

Q33820188-456D9383-0BB1-42B5-BAD2-044E9051BC9C

Q33820188-54C6C9C3-B24F-45C6-9ABF-D4363238E3D1

Q33820188-60773BC2-B8E2-452C-8289-87D976BAF370

Q33820188-66AF59E9-3475-4C76-B915-62AEF760957C

Q33820188-AF35A61B-5079-428B-98FE-6F51A4182584

Q33820188-C5D3A81C-DE67-4116-9DB0-9176AB7CE254

Q33820188-FFB66988-EF7B-4724-8DF2-04ABD3C1CB6F

P2860

Q33820188-002C8FE3-F3CE-48C4-BFC1-DF5BCABD80DA

Q33820188-04FE6921-C87A-49EA-9CB7-7C6808584F07

Q33820188-0BC9C2CE-ED18-425D-B71F-7383D969696E

Q33820188-111FDDA2-86A5-4D29-8FA3-7DB1C80B5A9D

Q33820188-17253CC2-A9C7-41DA-A585-B7A153EC7976

Q33820188-18534DB4-B4FB-4FF6-8414-FB25E8FDB7E7

Q33820188-1F8FEDCC-BFCC-437A-9D52-DB09FBB85925

Q33820188-212A6531-A68D-4162-BFA6-05BE35224952

Q33820188-255163AD-5FEB-40E2-9FB6-56B388B9B440

Q33820188-29F83B02-C03D-41FA-B541-5C91149A4796

P2888

Q33820188-99822801-11A6-4B35-B307-7158C4CC0148

P304

Q33820188-BD052C08-FA4E-4FB5-8E2C-D034129CB83F

P31

Q33820188-CFC6219A-3564-4712-9BB1-12BD93620112

P356

Q33820188-C1B4FA56-83A1-4B6B-A54A-251823503730

P478

Q33820188-13913CD1-47D5-4C91-9BE6-B611C5A3E44D

P50

Q33820188-23BE69DB-CD59-476B-BD86-720C0BCB4C5D

Q33820188-2695F288-C010-4D12-A18D-76D4129C4062

Q33820188-5DEE3773-374F-4638-9179-AD3B151DDF29

Q33820188-7F223D37-9FEF-47B4-A9A6-72E3C5D34404

Q33820188-8EEDBC97-5586-4339-A22D-45FCFE911675

Q33820188-F0E316D2-C96A-4C13-AE07-F28A271C0862

Q33820188-FECB8270-5049-467D-901E-2B28478D7BAA

P577

Q33820188-4339B8EA-D31B-4B2D-8F3B-F59A12B98FB5

P6179

Q33820188-300DF343-75AD-4E23-AB69-25072CFA2390

P698

Q33820188-85E0754E-81F7-4C14-A141-1166573C6612

P921

Q33820188-3CFC8F3C-60E8-4387-9039-188C8D42E971

P932

Q33820188-0ECDEFD9-639B-4344-8627-04104FAA73E3

P356

1471-244X-11-26

P1433

P1476

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study

@en

P2093

Ana Navarro

http://www.w3.org/2001/XMLSchema#string

Dolores Moreno

http://www.w3.org/2001/XMLSchema#string

Inmaculada Baeza

http://www.w3.org/2001/XMLSchema#string

Javier Gil

http://www.w3.org/2001/XMLSchema#string

Josefina Castro-Fornieles

http://www.w3.org/2001/XMLSchema#string

Juan Antonio Micó

http://www.w3.org/2001/XMLSchema#string

Mara Parellada

http://www.w3.org/2001/XMLSchema#string

Maria Olga Rojas-Corrales

http://www.w3.org/2001/XMLSchema#string

Montserrat Graell

http://www.w3.org/2001/XMLSchema#string

Soraya Otero

http://www.w3.org/2001/XMLSchema#string

P2860

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

Oxidative stress and neurodegeneration: where are we now?

Cytotoxic and genotoxic potential of dopamine.

Antioxidant activity applying an improved ABTS radical cation decolorization assay.

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.

Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene

Glutathione pathways in the brain.

Annotation: childhood-onset schizophrenia: clinical and treatment issues.

P2888

1471-244x-11-26

P304

26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-244X-11-26

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Mónica Martinez-Cengotitabengoa

Ana González-Pinto

Juan Gibert-Rahola

Cesar A. Soutullo

P577

2011-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1015474623

http://www.w3.org/2001/XMLSchema#string

P698

21320302

http://www.w3.org/2001/XMLSchema#string

P921

P932

3045298

http://www.w3.org/2001/XMLSchema#string